JP2009516501A5 - - Google Patents

Download PDF

Info

Publication number
JP2009516501A5
JP2009516501A5 JP2008532468A JP2008532468A JP2009516501A5 JP 2009516501 A5 JP2009516501 A5 JP 2009516501A5 JP 2008532468 A JP2008532468 A JP 2008532468A JP 2008532468 A JP2008532468 A JP 2008532468A JP 2009516501 A5 JP2009516501 A5 JP 2009516501A5
Authority
JP
Japan
Prior art keywords
risk
distant metastasis
patient
distant
expression profile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008532468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009516501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/037203 external-priority patent/WO2007038402A1/en
Publication of JP2009516501A publication Critical patent/JP2009516501A/ja
Publication of JP2009516501A5 publication Critical patent/JP2009516501A5/ja
Pending legal-status Critical Current

Links

JP2008532468A 2005-09-22 2006-09-22 鼻咽腔癌の予後的サブクラスの同定のための遺伝子発現プロファイリング Pending JP2009516501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71917105P 2005-09-22 2005-09-22
US72112905P 2005-09-28 2005-09-28
PCT/US2006/037203 WO2007038402A1 (en) 2005-09-22 2006-09-22 Gene expression profiling for identification of prognostic subclasses in nasopharyngeal carcinomas

Publications (2)

Publication Number Publication Date
JP2009516501A JP2009516501A (ja) 2009-04-23
JP2009516501A5 true JP2009516501A5 (https=) 2011-01-06

Family

ID=37596251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532468A Pending JP2009516501A (ja) 2005-09-22 2006-09-22 鼻咽腔癌の予後的サブクラスの同定のための遺伝子発現プロファイリング

Country Status (13)

Country Link
US (1) US7998674B2 (https=)
EP (1) EP1934862A1 (https=)
JP (1) JP2009516501A (https=)
KR (1) KR20080063343A (https=)
CN (2) CN102346816B (https=)
AU (1) AU2006294880A1 (https=)
BR (1) BRPI0616139A2 (https=)
CA (1) CA2623403A1 (https=)
IL (1) IL190253A0 (https=)
NO (1) NO20081925L (https=)
RU (1) RU2008115113A (https=)
TW (1) TW200729050A (https=)
WO (1) WO2007038402A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
US20090226912A1 (en) * 2007-12-21 2009-09-10 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9684001B2 (en) 2008-02-07 2017-06-20 Ranju Ralhan Biomarkers for head-and-neck cancers and precancers
CA2618163A1 (en) 2008-02-07 2009-08-07 K. W. Michael Siu Head and neck cancer biomarkers
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
EP2334826A4 (en) * 2008-09-12 2012-01-25 Cancer Res Initiative Foundation PROCEDURE FOR THE DETECTION AND DIAGNOSIS OF ORAL AND NASOPHARYNGEAL TUMORS
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) * 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
WO2010056374A2 (en) * 2008-11-17 2010-05-20 Veracyte, Inc. Methods and compositions of molecular profiling for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
WO2011116380A2 (en) 2010-03-19 2011-09-22 H. Lee Moffitt Cancer Center And Research Institute, Inc. Hybrid model for the classification of carcinoma subtypes
WO2012031207A2 (en) 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
CN102732484B (zh) * 2012-07-10 2015-04-22 广东医学院 一种人鼻咽癌肿瘤干细胞系建立方法
DK3435084T3 (da) 2012-08-16 2023-05-30 Mayo Found Medical Education & Res Prostatakræftprognose under anvendelse af biomarkører
CN103020454A (zh) * 2012-12-15 2013-04-03 中国科学院深圳先进技术研究院 发病关键因素提取与疾病预警方法及系统
KR101711584B1 (ko) * 2012-12-18 2017-03-02 재단법인 의약바이오컨버젼스연구단 변형된 eprs 단백질의 결정 구조 및 이의 결정화 방법
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
EP3215170A4 (en) 2014-11-05 2018-04-25 Veracyte, Inc. Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
EP3504348B1 (en) 2016-08-24 2022-12-14 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
EP3571322B9 (en) 2017-01-20 2023-10-04 VERACYTE SD, Inc. Molecular subtyping, prognosis, and treatment of bladder cancer
EP3593140A4 (en) 2017-03-09 2021-01-06 Decipher Biosciences, Inc. SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY
CA3062716A1 (en) 2017-05-12 2018-11-15 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
WO2019028285A2 (en) 2017-08-04 2019-02-07 Genomedx, Inc. USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
CN109801680B (zh) * 2018-12-03 2023-02-28 广州中医药大学(广州中医药研究院) 基于tcga数据库的肿瘤转移复发预测方法及系统
CN111382217B (zh) * 2018-12-29 2025-06-24 北京奇虎科技有限公司 一种目的地推荐方法和装置
CN120473159B (zh) * 2025-07-14 2025-09-26 泛肽生物科技(浙江)有限公司 一种鼻咽癌远处转移预测模型的构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143539A1 (en) 2000-12-08 2003-07-31 Francois Bertucci Gene expression profiling of primary breast carcinomas using arrays of candidate genes
US20030014539A1 (en) * 2001-06-12 2003-01-16 Reznick Josh L. System and method for traffic management
GB0201498D0 (en) * 2002-01-23 2002-03-13 Biotech Res Ventures Pte Ltd Materials and methods for treating cancer
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation
CN1482256A (zh) * 2002-09-13 2004-03-17 中南大学 鼻咽癌分子标志物—brd7试剂盒
CN1445546A (zh) * 2003-01-08 2003-10-01 中山大学肿瘤防治中心 鼻咽癌早期诊断试剂盒

Similar Documents

Publication Publication Date Title
JP2009516501A5 (https=)
Mathur et al. Gene set analysis methods: a systematic comparison
TWI879133B (zh) 用於標靶定序之模型
Frost Variance-adjusted Mahalanobis (VAM): a fast and accurate method for cell-specific gene set scoring
Liao et al. Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
JP2009523028A5 (https=)
Kuan et al. Integrating prior knowledge in multiple testing under dependence with applications to detecting differential DNA methylation
AU2016291558A1 (en) Markers of stroke and stroke severity
Chen et al. DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups
RU2008115113A (ru) Профилирование генной экспрессии для идентификации прогностических субклассов при карциноме носоглотки
US20200239964A1 (en) Anomalous fragment detection and classification
US20250118439A1 (en) Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
CN107679367A (zh) 一种基于网络节点关联度的共调控网络功能模块识别方法及系统
Wang et al. A robust blood gene expression-based prognostic model for castration-resistant prostate cancer
Hatano et al. Comparison between mathematical models of intermittent androgen suppression for prostate cancer
Chung et al. Recent technologies towards diagnostic and therapeutic applications of circulating nucleic acids in colorectal cancers
Yu et al. Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
Benson III et al. Path toward prognostication and prediction: an evolving matrix
Tran A novel method for finding non-small cell lung cancer diagnosis biomarkers
Zhang et al. Dissecting the role of N6-methylandenosine-related long non-coding RNAs signature in prognosis and immune microenvironment of breast cancer
CN105200124A (zh) 用于肿瘤特征和标记物组鉴定,肿瘤分级的方法和用于癌的标记物组
Wei et al. An efficient and easy-to-use network-based integrative method of multi-omics data for cancer genes discovery
Shokoohi et al. Uncovering alterations in cancer epigenetics via trans-dimensional Markov chain Monte Carlo and hidden Markov models
Koo et al. Prediction of tumor purity from gene expression data using machine learning
Yousef Personalized cancer genomics: the road map to clinical implementation